Fimecs

About:

FIMECS is a drug discovery company that develops protein degradation therapeutics for cancers and difficult-to-treat diseases.

Website: https://www.fimecs.com/

Twitter/X: fimecs

Top Investors: Takeda, ANRI, Kyoto University Innovation Capital, UTokyo Innovation Platform, Cosmo Bio

Description:

FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300 proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable.